1. Home
  2. CBL vs ARDX Comparison

CBL vs ARDX Comparison

Compare CBL & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CBL
  • ARDX
  • Stock Information
  • Founded
  • CBL 1978
  • ARDX 2007
  • Country
  • CBL United States
  • ARDX United States
  • Employees
  • CBL N/A
  • ARDX N/A
  • Industry
  • CBL Real Estate Investment Trusts
  • ARDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CBL Real Estate
  • ARDX Health Care
  • Exchange
  • CBL Nasdaq
  • ARDX Nasdaq
  • Market Cap
  • CBL 938.8M
  • ARDX 882.9M
  • IPO Year
  • CBL 1993
  • ARDX 2014
  • Fundamental
  • Price
  • CBL $32.51
  • ARDX $5.87
  • Analyst Decision
  • CBL
  • ARDX Strong Buy
  • Analyst Count
  • CBL 0
  • ARDX 10
  • Target Price
  • CBL N/A
  • ARDX $10.65
  • AVG Volume (30 Days)
  • CBL 102.1K
  • ARDX 4.3M
  • Earning Date
  • CBL 11-06-2025
  • ARDX 10-30-2025
  • Dividend Yield
  • CBL 5.53%
  • ARDX N/A
  • EPS Growth
  • CBL 297.30
  • ARDX N/A
  • EPS
  • CBL 4.02
  • ARDX N/A
  • Revenue
  • CBL $553,643,000.00
  • ARDX $398,234,000.00
  • Revenue This Year
  • CBL N/A
  • ARDX $18.90
  • Revenue Next Year
  • CBL N/A
  • ARDX $31.52
  • P/E Ratio
  • CBL $8.06
  • ARDX N/A
  • Revenue Growth
  • CBL 5.74
  • ARDX 58.12
  • 52 Week Low
  • CBL $21.10
  • ARDX $3.21
  • 52 Week High
  • CBL $33.54
  • ARDX $6.78
  • Technical
  • Relative Strength Index (RSI)
  • CBL 66.13
  • ARDX 56.05
  • Support Level
  • CBL $29.07
  • ARDX $5.56
  • Resistance Level
  • CBL $33.10
  • ARDX $6.25
  • Average True Range (ATR)
  • CBL 0.68
  • ARDX 0.35
  • MACD
  • CBL 0.29
  • ARDX 0.06
  • Stochastic Oscillator
  • CBL 84.85
  • ARDX 52.20

About CBL CBL & Associates Properties Inc.

CBL & Associates Properties Inc is a real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: